We aspire to help patients and clinicians confront the most challenging cancers in modern medicine

Kazia’s drug candidates are designed to treat diseases such as brain cancer, renal cancer, and liver cancer, which are poorly served by existing therapies

We work at the cutting edge of scientific innovation to find new approaches to cancer treatment

Kazia’s international team harnesses a detailed understanding of the molecular pathways driving cancer to deliver drug candidates which are first-in-class or best-in-class

We draw on the best research available, and partner with the world’s leading experts in cancer treatment

Kazia’s unique strength lies in the ability to identify promising undervalued drug candidates around the world, and to collaborate with researchers to discover and develop their potential

News

Insights

Resources

Stock Information
Symbol
ASX:
Price
Change
()
Volume
Low / High
/
Market Cap
Stock Information
Symbol
NASDAQ:
Price
Change
()
Volume
Low / High
/
Market Cap